Alison Dowling
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $772, more than ten times the $49 reported in 2023.
Across 67 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$185
- Amgen$130
- AbbVie$125
- Novo Nordisk$111
- AstraZeneca$97
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$64
- plus $533 from 18 others
What the payments were for
- Food & beverage$1,244100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $185 |
| Amgen | 8 | $130 |
| AbbVie | 6 | $125 |
| Novo Nordisk | 7 | $111 |
| AstraZeneca | 6 | $97 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $64 |
| Acadia Pharmaceuticals Inc | 3 | $55 |
| Viatris Specialty LLC | 2 | $46 |
| Dexcom, Inc. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $37 |
| Novartis | 2 | $37 |
| Pfizer | 2 | $33 |
| Lundbeck LLC | 2 | $33 |
| Merck | 2 | $32 |
| Vertex | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Mylan Specialty L.p. | 1 | $22 |
| Baxter Healthcare | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $14 |
How this compares
$1,244 in reported general payments places this provider in the 70th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $751 |
| Celecoxib | 33 | $638 |
| Gabapentin | 24 | $478 |
| Omeprazole | 22 | $356 |
| Fluticasone Propionate | 13 | $324 |
| Ropinirole Hcl | 18 | $291 |
| Duloxetine Hcl | 15 | $249 |
| Buspirone Hcl | 22 | $228 |
| Pantoprazole Sodium | 20 | $228 |
| Cephalexin | 21 | $161 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $155 |
| Sertraline Hcl | 34 | $125 |
| Cyclobenzaprine Hcl | 11 | $121 |
| Lisinopril | 33 | $115 |
| Tizanidine Hcl | 13 | $114 |
Paid to pharmacies, not to this prescriber.
Other family in Macon
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
- Jennifer GriggColumbia$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.